Gene · 7334
Papers2,223
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,223
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| EpCAM-PSMA: Potential predictors of treatment outcomes for PSMA-targeted alpha therapies in metastatic castration-resistant prostate cancer. | Mol Ther Oncol | 2026 | 41732759 | PubTator, text mining | PubMed |
| CRISPR-based chemogenomic profiling reveals redox vulnerabilities to epigallocatechin-3-gallate and green tea polyphenol extract. | Redox Biol | 2026 | 41581373 | PubTator, text mining | PubMed |
| Otubain deubiquitinases: Multi-layered regulators of cell fate, development, and stress responses across kingdoms. | iScience | 2026 | 41550777 | PubTator, text mining | PubMed |
| Development and validation of a prognostic model based on T cell signature genes in colon cancer using single-cell RNA sequencing. | Clin Exp Med | 2026 | 41483215 | PubTator, text mining | PubMed |
| MIR4435-2HG promotes breast cancer evolution through miR-205-5p/UBE2N axis and exosome-mediated macrophage M2-like polarization. | Cell Signal | 2026 | 41317936 | PubTator, text mining | PubMed |
| MICRO-TAG enzyme complementation enables quantification of cellular drug-target engagement in temperature series. | SLAS Discov | 2026 | 41285198 | PubTator, text mining | PubMed |
| Stool- and Blood-Associated Colorectal Cancer Biomarkers: A Systematic Review. | Cancers (Basel) | 2025 | 41514609 | PubTator, text mining | PubMed |
| Study on the Mechanism of Aspirin Alleviating Kawasaki Disease With Coronary Artery Lesions by Inducing TRAF6 to Regulate STAT3 Ubiquitination and Inhibit Th17 Cell Differentiation. | Drug Dev Res | 2025 | 41320749 | PubTator, text mining | PubMed |
| UBE2N as a novel prognostic and therapeutic biomarker of lung adenocarcinoma. | Front Immunol | 2025 | 40861472 | PubTator, text mining | PubMed |
| Episodic transport of protein aggregates achieves a positive size selectivity in aggresome formation. | Nat Commun | 2025 | 40846843 | PubTator, text mining | PubMed |
| Role of Ionizing Radiation in Shaping the Complex Multi-Layered Epigenome. | Epigenomes | 2025 | 40843671 | PubTator, text mining | PubMed |
| Investigating the Cellular Responses to Combined Nisin and Urolithin B Treatment (7:3) in HKB-11 Lymphoma Cells. | Int J Mol Sci | 2025 | 40806497 | PubTator, text mining | PubMed |
| Whole-exome sequencing identifies TRIM72 as a candidate gene for autosomal recessive limb-girdle muscular dystrophy. | Hum Genomics | 2025 | 40804694 | PubTator, text mining | PubMed |
| Necroptosis in cancer: insight from epigenetic, post-transcriptional and post-translational modifications. | J Hematol Oncol | 2025 | 40739259 | PubTator, text mining | PubMed |
| USP1/UAF1 targets polyubiquitinated PCNA with an exo-cleavage mechanism that can temporarily enrich for monoubiquitinated PCNA. | Nat Commun | 2025 | 40739138 | PubTator, text mining | PubMed |
| The P132H mutation of SARS-CoV-2 NSP5 relieves its inhibition on interferon-β activation via blocking MAVS degradation. | Cell Mol Life Sci | 2025 | 40736574 | PubTator, text mining | PubMed |
| DeepNanoHi-C: deep learning enables accurate single-cell nanopore long-read data analysis and 3D genome interpretation. | Nucleic Acids Res | 2025 | 40637236 | PubTator, text mining | PubMed |
| UBE2D1 as a key biomarker in systemic juvenile idiopathic arthritis: a new perspective on diagnosis and disease activity assessment. | Arthritis Res Ther | 2025 | 40635084 | PubTator, text mining | PubMed |
| UBE2N inhibition abrogates cancer chemoresistance and metastasis in lung adenocarcinoma. | Cancer Gene Ther | 2025 | 40544189 | PubTator, text mining | PubMed |
| Covalent inhibition of Plasmodium falciparum Ubc13 impairs global protein synthesis. | iScience | 2025 | 40491475 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7334/papers?page=2